Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Strijbos

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
ESMO Open|November 16, 2016
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaAlejo Rodriguez-Vida, Michiel Strijbos, Thomas Hutson
Oncology Research and Treatment|January 15, 2023
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with CancerKarin Jordan, Evandro De Azambuja, Teresa Amaral, et al.
Prostate Cancer and Prostatic Diseases|November 24, 2020
Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancerSteffi Oeyen, Vincent Liégeois, Bram De Laere, et al.
Clinical Genitourinary Cancer|May 28, 2014
Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysisBenoit Beuselinck, Evelyne Lerut, Pascal Wolter, et al.
European Urology Oncology|September 25, 2025
Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER TrialFleur Kleiburg, Piet Dirix, Valérie Fonteyne, et al.
The Breast Journal|August 12, 2020
Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patientsMelanie Machiels, Reinhilde Weytjens, Katrien Erven, et al.
BJU International|November 13, 2013
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinibBenoit Beuselinck, Yann-Alexandre Vano, Stéphane Oudard, et al.
Future Oncology (London, England)|May 2, 2020
Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomyPiet Dirix, Michiel Strijbos, Tom Van den Mooter, et al.
ESMO Open|February 22, 2018
Global cancer control: responding to the growing burden, rising costs and inequalities in accessGerald W Prager, Sofia Braga, Branislav Bystricky, et al.
The Prostate|February 13, 2018
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancerBram De Laere, Steffi Oeyen, Peter Van Oyen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
ESMO Open|November 16, 2016
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaAlejo Rodriguez-Vida, Michiel Strijbos, Thomas Hutson
Oncology Research and Treatment|January 15, 2023
Medical Oncology Education in Europe: Equipping Medical Oncologists to Provide the Best Care for Patients with CancerKarin Jordan, Evandro De Azambuja, Teresa Amaral, et al.
Prostate Cancer and Prostatic Diseases|November 24, 2020
Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancerSteffi Oeyen, Vincent Liégeois, Bram De Laere, et al.
Clinical Genitourinary Cancer|May 28, 2014
Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysisBenoit Beuselinck, Evelyne Lerut, Pascal Wolter, et al.
European Urology Oncology|September 25, 2025
Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER TrialFleur Kleiburg, Piet Dirix, Valérie Fonteyne, et al.
The Breast Journal|August 12, 2020
Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patientsMelanie Machiels, Reinhilde Weytjens, Katrien Erven, et al.
BJU International|November 13, 2013
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinibBenoit Beuselinck, Yann-Alexandre Vano, Stéphane Oudard, et al.
Future Oncology (London, England)|May 2, 2020
Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomyPiet Dirix, Michiel Strijbos, Tom Van den Mooter, et al.
ESMO Open|February 22, 2018
Global cancer control: responding to the growing burden, rising costs and inequalities in accessGerald W Prager, Sofia Braga, Branislav Bystricky, et al.
The Prostate|February 13, 2018
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancerBram De Laere, Steffi Oeyen, Peter Van Oyen, et al.
Pageof 2